S100A8 and S100A9 in hematologic Malignancies: from development to therapy
F Razmkhah, S Kim, S Lim, AJ Dania… - International journal of …, 2023 - mdpi.com
S100A8 and S100A9 are multifunctional proteins that can initiate various signaling
pathways and modulate cell function both inside and outside immune cells, depending on …
pathways and modulate cell function both inside and outside immune cells, depending on …
Calprotectin as new potential clinical marker for multiple myeloma
Increased levels of inflammatory cytokines in multiple myeloma (MM) patients and the role of
inflammation in disease pathogenesis, have recently been considered. The aim of this study …
inflammation in disease pathogenesis, have recently been considered. The aim of this study …
芦可替尼治疗骨髓纤维化患者的疗效及其预测模型
张雪皎， 王跃， 谭云山， 刘澎 - 中国癌症防治杂志, 2021 - zgazfz.com
目的探讨芦可替尼治疗骨髓纤维化的疗效及其预测指标. 方法选取2017 年11 月至2020 年12
月在复旦大学附属中山医院血液科诊治的采用芦可替尼治疗的64 例骨髓纤维化患者为研究对象 …
月在复旦大学附属中山医院血液科诊治的采用芦可替尼治疗的64 例骨髓纤维化患者为研究对象 …
The importance of serum calprotectin level in patients with lymphoma
G Sincan, E Ayvaz, F Erdem… - Iraqi Journal of …, 2023 - journals.lww.com
BACKGROUND: Calprotectin is a protein found in the cytoplasm of neutrophils and
monocytes and its serum level increases in inflammatory conditions and some cancer cases …
monocytes and its serum level increases in inflammatory conditions and some cancer cases …